nodes	percent_of_prediction	percent_of_DWPC	metapath
Rosiglitazone—type 2 diabetes mellitus—obesity	0.415	1	CtDrD
Rosiglitazone—PPARG—obesity	0.115	0.727	CbGaD
Rosiglitazone—Tripelennamine—Benzphetamine—obesity	0.101	1	CrCrCtD
Rosiglitazone—ALB—obesity	0.0433	0.273	CbGaD
Rosiglitazone—CYP2A6—Bupropion—obesity	0.0319	0.164	CbGbCtD
Rosiglitazone—CYP2C8—Bupropion—obesity	0.0157	0.0807	CbGbCtD
Rosiglitazone—CYP1A2—Phentermine—obesity	0.0143	0.0735	CbGbCtD
Rosiglitazone—CYP1A2—Phenylpropanolamine—obesity	0.0137	0.0701	CbGbCtD
Rosiglitazone—CYP2C9—Phentermine—obesity	0.0129	0.0662	CbGbCtD
Rosiglitazone—CYP1A2—Bupropion—obesity	0.0122	0.0625	CbGbCtD
Rosiglitazone—CYP2D6—Phentermine—obesity	0.0118	0.0606	CbGbCtD
Rosiglitazone—CYP2C8—Cimetidine—obesity	0.0115	0.0593	CbGbCtD
Rosiglitazone—CYP2C9—Bupropion—obesity	0.011	0.0563	CbGbCtD
Rosiglitazone—CYP2D6—Bupropion—obesity	0.01	0.0515	CbGbCtD
Rosiglitazone—CYP2C19—Cimetidine—obesity	0.00968	0.0497	CbGbCtD
Rosiglitazone—CYP2D6—Methamphetamine—obesity	0.00943	0.0484	CbGbCtD
Rosiglitazone—CYP1A2—Cimetidine—obesity	0.00894	0.0459	CbGbCtD
Rosiglitazone—CYP2C9—Cimetidine—obesity	0.00805	0.0413	CbGbCtD
Rosiglitazone—CYP2D6—Cimetidine—obesity	0.00736	0.0378	CbGbCtD
Rosiglitazone—CYP2C19—Topiramate—obesity	0.00634	0.0325	CbGbCtD
Rosiglitazone—PPARG—brown adipose tissue—obesity	0.00208	0.119	CbGeAlD
Rosiglitazone—Ligament sprain—Bupropion—obesity	0.00128	0.0282	CcSEcCtD
Rosiglitazone—ACSL4—islet of Langerhans—obesity	0.000979	0.0559	CbGeAlD
Rosiglitazone—ACSL4—respiratory system—obesity	0.000925	0.0528	CbGeAlD
Rosiglitazone—ACSL4—adrenal cortex—obesity	0.000776	0.0443	CbGeAlD
Rosiglitazone—ACSL4—cardiovascular system—obesity	0.000708	0.0405	CbGeAlD
Rosiglitazone—Multiple fractures—Orlistat—obesity	0.000662	0.0145	CcSEcCtD
Rosiglitazone—Fracture—Orlistat—obesity	0.000662	0.0145	CcSEcCtD
Rosiglitazone—ALB—gall bladder—obesity	0.00063	0.036	CbGeAlD
Rosiglitazone—ACSL4—pituitary gland—obesity	0.000627	0.0358	CbGeAlD
Rosiglitazone—Cardiac failure—Phentermine—obesity	0.000626	0.0137	CcSEcCtD
Rosiglitazone—ACSL4—adipose tissue—obesity	0.000624	0.0357	CbGeAlD
Rosiglitazone—Cerebrovascular accident—Phentermine—obesity	0.000624	0.0137	CcSEcCtD
Rosiglitazone—ACSL4—digestive system—obesity	0.000588	0.0336	CbGeAlD
Rosiglitazone—Hepatic failure—Cimetidine—obesity	0.000563	0.0123	CcSEcCtD
Rosiglitazone—Pioglitazone—PPARG—obesity	0.000562	1	CrCbGaD
Rosiglitazone—ACSL4—adrenal gland—obesity	0.00056	0.032	CbGeAlD
Rosiglitazone—Cerebrovascular accident—Diethylpropion—obesity	0.000543	0.0119	CcSEcCtD
Rosiglitazone—Hyperlipidaemia—Sibutramine—obesity	0.000517	0.0113	CcSEcCtD
Rosiglitazone—ACSL4—endocrine gland—obesity	0.000486	0.0278	CbGeAlD
Rosiglitazone—Acute coronary syndrome—Phentermine—obesity	0.000464	0.0102	CcSEcCtD
Rosiglitazone—Myocardial infarction—Phentermine—obesity	0.000462	0.0101	CcSEcCtD
Rosiglitazone—PPARG—islet of Langerhans—obesity	0.00044	0.0252	CbGeAlD
Rosiglitazone—ACSL4—liver—obesity	0.000438	0.025	CbGeAlD
Rosiglitazone—PPARG—respiratory system—obesity	0.000416	0.0238	CbGeAlD
Rosiglitazone—Hyperbilirubinaemia—Sibutramine—obesity	0.000409	0.00897	CcSEcCtD
Rosiglitazone—Hypercholesterolaemia—Sibutramine—obesity	0.000394	0.00863	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Cimetidine—obesity	0.000387	0.00847	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Methamphetamine—obesity	0.000361	0.00791	CcSEcCtD
Rosiglitazone—Constipation—Methamphetamine—obesity	0.000358	0.00784	CcSEcCtD
Rosiglitazone—Fluid retention—Sibutramine—obesity	0.000354	0.00775	CcSEcCtD
Rosiglitazone—Hepatitis—Cimetidine—obesity	0.00035	0.00767	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Benzphetamine—obesity	0.000348	0.00763	CcSEcCtD
Rosiglitazone—Visual acuity reduced—Topiramate—obesity	0.000348	0.00762	CcSEcCtD
Rosiglitazone—Hepatic enzyme increased—Bupropion—obesity	0.000343	0.00752	CcSEcCtD
Rosiglitazone—Hypercholesterolaemia—Bupropion—obesity	0.000343	0.00752	CcSEcCtD
Rosiglitazone—Urticaria—Methamphetamine—obesity	0.000332	0.00728	CcSEcCtD
Rosiglitazone—Erythema multiforme—Cimetidine—obesity	0.000331	0.00725	CcSEcCtD
Rosiglitazone—CYP2A6—adipose tissue—obesity	0.00033	0.0189	CbGeAlD
Rosiglitazone—Diabetes mellitus—Orlistat—obesity	0.000321	0.00704	CcSEcCtD
Rosiglitazone—Urticaria—Benzphetamine—obesity	0.00032	0.00702	CcSEcCtD
Rosiglitazone—PPARG—cardiovascular system—obesity	0.000319	0.0182	CbGeAlD
Rosiglitazone—Hypertension—Phentermine—obesity	0.000318	0.00696	CcSEcCtD
Rosiglitazone—Constipation—Phendimetrazine—obesity	0.000314	0.00689	CcSEcCtD
Rosiglitazone—Hepatic failure—Orlistat—obesity	0.000311	0.00681	CcSEcCtD
Rosiglitazone—Diabetes mellitus—Sibutramine—obesity	0.000311	0.00681	CcSEcCtD
Rosiglitazone—Hepatic function abnormal—Sibutramine—obesity	0.000309	0.00678	CcSEcCtD
Rosiglitazone—SLCO1B1—digestive system—obesity	0.000307	0.0175	CbGeAlD
Rosiglitazone—Oedema—Phentermine—obesity	0.0003	0.00658	CcSEcCtD
Rosiglitazone—CYP2D6—hindbrain—obesity	0.000299	0.0171	CbGeAlD
Rosiglitazone—Cardiac failure congestive—Sibutramine—obesity	0.000298	0.00653	CcSEcCtD
Rosiglitazone—Increased appetite—Orlistat—obesity	0.000297	0.00651	CcSEcCtD
Rosiglitazone—Increased appetite—Sibutramine—obesity	0.000288	0.0063	CcSEcCtD
Rosiglitazone—Hyperlipidaemia—Topiramate—obesity	0.000287	0.00629	CcSEcCtD
Rosiglitazone—Leukopenia—Diethylpropion—obesity	0.000287	0.00628	CcSEcCtD
Rosiglitazone—Hypoglycaemia—Orlistat—obesity	0.000286	0.00627	CcSEcCtD
Rosiglitazone—Diarrhoea—Methamphetamine—obesity	0.000286	0.00627	CcSEcCtD
Rosiglitazone—PPARG—adipose tissue—obesity	0.000281	0.0161	CbGeAlD
Rosiglitazone—Hypoglycaemia—Sibutramine—obesity	0.000277	0.00607	CcSEcCtD
Rosiglitazone—Dizziness—Methamphetamine—obesity	0.000276	0.00606	CcSEcCtD
Rosiglitazone—Diarrhoea—Benzphetamine—obesity	0.000276	0.00605	CcSEcCtD
Rosiglitazone—Cerebrovascular accident—Sibutramine—obesity	0.000276	0.00604	CcSEcCtD
Rosiglitazone—Leukopenia—Cimetidine—obesity	0.000273	0.00598	CcSEcCtD
Rosiglitazone—Myalgia—Diethylpropion—obesity	0.000273	0.00597	CcSEcCtD
Rosiglitazone—Hepatic function abnormal—Bupropion—obesity	0.00027	0.00591	CcSEcCtD
Rosiglitazone—Constipation—Phenylpropanolamine—obesity	0.000268	0.00588	CcSEcCtD
Rosiglitazone—Dizziness—Benzphetamine—obesity	0.000267	0.00584	CcSEcCtD
Rosiglitazone—PPARG—digestive system—obesity	0.000264	0.0151	CbGeAlD
Rosiglitazone—Headache—Methamphetamine—obesity	0.000262	0.00574	CcSEcCtD
Rosiglitazone—Myalgia—Cimetidine—obesity	0.000259	0.00568	CcSEcCtD
Rosiglitazone—Arthralgia—Cimetidine—obesity	0.000259	0.00568	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Phentermine—obesity	0.000259	0.00568	CcSEcCtD
Rosiglitazone—Fatigue—Phentermine—obesity	0.000259	0.00568	CcSEcCtD
Rosiglitazone—Constipation—Phentermine—obesity	0.000257	0.00563	CcSEcCtD
Rosiglitazone—CYP1A2—respiratory system—obesity	0.000257	0.0147	CbGeAlD
Rosiglitazone—SLCO1B1—endocrine gland—obesity	0.000253	0.0145	CbGeAlD
Rosiglitazone—Headache—Benzphetamine—obesity	0.000253	0.00554	CcSEcCtD
Rosiglitazone—PPARG—adrenal gland—obesity	0.000252	0.0144	CbGeAlD
Rosiglitazone—Diarrhoea—Phendimetrazine—obesity	0.000251	0.00551	CcSEcCtD
Rosiglitazone—Increased appetite—Bupropion—obesity	0.000251	0.0055	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Cimetidine—obesity	0.000249	0.00545	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Cimetidine—obesity	0.000243	0.00534	CcSEcCtD
Rosiglitazone—Dizziness—Phendimetrazine—obesity	0.000243	0.00533	CcSEcCtD
Rosiglitazone—Hypoglycaemia—Bupropion—obesity	0.000241	0.00529	CcSEcCtD
Rosiglitazone—Cerebrovascular accident—Bupropion—obesity	0.00024	0.00527	CcSEcCtD
Rosiglitazone—Nausea—Benzphetamine—obesity	0.000239	0.00525	CcSEcCtD
Rosiglitazone—Urticaria—Phentermine—obesity	0.000239	0.00523	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Diethylpropion—obesity	0.000238	0.00522	CcSEcCtD
Rosiglitazone—ALB—adrenal gland—obesity	0.000236	0.0135	CbGeAlD
Rosiglitazone—CYP2A6—liver—obesity	0.000231	0.0132	CbGeAlD
Rosiglitazone—Headache—Phendimetrazine—obesity	0.00023	0.00504	CcSEcCtD
Rosiglitazone—SLCO1B1—liver—obesity	0.000228	0.0131	CbGeAlD
Rosiglitazone—Musculoskeletal discomfort—Cimetidine—obesity	0.000227	0.00496	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Diethylpropion—obesity	0.000226	0.00494	CcSEcCtD
Rosiglitazone—Upper respiratory tract infection—Orlistat—obesity	0.000224	0.00492	CcSEcCtD
Rosiglitazone—Constipation—Diethylpropion—obesity	0.000223	0.0049	CcSEcCtD
Rosiglitazone—PTGS1—respiratory system—obesity	0.000222	0.0127	CbGeAlD
Rosiglitazone—Hepatic enzyme increased—Topiramate—obesity	0.000219	0.00479	CcSEcCtD
Rosiglitazone—PPARG—endocrine gland—obesity	0.000219	0.0125	CbGeAlD
Rosiglitazone—Nausea—Phendimetrazine—obesity	0.000218	0.00478	CcSEcCtD
Rosiglitazone—Asthenia—Phentermine—obesity	0.000216	0.00472	CcSEcCtD
Rosiglitazone—Fatigue—Cimetidine—obesity	0.000214	0.0047	CcSEcCtD
Rosiglitazone—Constipation—Cimetidine—obesity	0.000213	0.00466	CcSEcCtD
Rosiglitazone—Weight increased—Sibutramine—obesity	0.000213	0.00466	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Sibutramine—obesity	0.000211	0.00462	CcSEcCtD
Rosiglitazone—Nasopharyngitis—Bupropion—obesity	0.000211	0.00462	CcSEcCtD
Rosiglitazone—Urticaria—Diethylpropion—obesity	0.000208	0.00455	CcSEcCtD
Rosiglitazone—Dizziness—Phenylpropanolamine—obesity	0.000208	0.00455	CcSEcCtD
Rosiglitazone—Diarrhoea—Phentermine—obesity	0.000206	0.0045	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Sibutramine—obesity	0.000205	0.0045	CcSEcCtD
Rosiglitazone—Myocardial infarction—Sibutramine—obesity	0.000204	0.00447	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Orlistat—obesity	0.000204	0.00446	CcSEcCtD
Rosiglitazone—Sinusitis—Orlistat—obesity	0.000202	0.00443	CcSEcCtD
Rosiglitazone—CYP2C19—digestive system—obesity	0.0002	0.0114	CbGeAlD
Rosiglitazone—Dizziness—Phentermine—obesity	0.000199	0.00435	CcSEcCtD
Rosiglitazone—Rash—Phenylpropanolamine—obesity	0.000198	0.00434	CcSEcCtD
Rosiglitazone—Dermatitis—Phenylpropanolamine—obesity	0.000198	0.00433	CcSEcCtD
Rosiglitazone—PPARG—liver—obesity	0.000197	0.0113	CbGeAlD
Rosiglitazone—Fluid retention—Topiramate—obesity	0.000196	0.0043	CcSEcCtD
Rosiglitazone—Sinusitis—Sibutramine—obesity	0.000195	0.00428	CcSEcCtD
Rosiglitazone—Hepatitis—Orlistat—obesity	0.000193	0.00423	CcSEcCtD
Rosiglitazone—Oedema peripheral—Orlistat—obesity	0.00019	0.00417	CcSEcCtD
Rosiglitazone—Rash—Phentermine—obesity	0.000189	0.00415	CcSEcCtD
Rosiglitazone—Upper respiratory tract infection—Bupropion—obesity	0.000189	0.00415	CcSEcCtD
Rosiglitazone—Dermatitis—Phentermine—obesity	0.000189	0.00415	CcSEcCtD
Rosiglitazone—Headache—Phentermine—obesity	0.000188	0.00412	CcSEcCtD
Rosiglitazone—CYP2C9—cardiovascular system—obesity	0.000187	0.0107	CbGeAlD
Rosiglitazone—Nausea—Phenylpropanolamine—obesity	0.000186	0.00409	CcSEcCtD
Rosiglitazone—CYP2C8—pituitary gland—obesity	0.000186	0.0106	CbGeAlD
Rosiglitazone—Weight increased—Bupropion—obesity	0.000185	0.00406	CcSEcCtD
Rosiglitazone—ALB—liver—obesity	0.000185	0.0106	CbGeAlD
Rosiglitazone—Oedema peripheral—Sibutramine—obesity	0.000184	0.00404	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Bupropion—obesity	0.000184	0.00403	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Bupropion—obesity	0.00018	0.00395	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Bupropion—obesity	0.000179	0.00392	CcSEcCtD
Rosiglitazone—Diarrhoea—Diethylpropion—obesity	0.000179	0.00392	CcSEcCtD
Rosiglitazone—Nausea—Phentermine—obesity	0.000178	0.00391	CcSEcCtD
Rosiglitazone—Asthenia—Cimetidine—obesity	0.000178	0.00391	CcSEcCtD
Rosiglitazone—Myocardial infarction—Bupropion—obesity	0.000178	0.0039	CcSEcCtD
Rosiglitazone—Eye disorder—Sibutramine—obesity	0.000175	0.00383	CcSEcCtD
Rosiglitazone—Immune system disorder—Orlistat—obesity	0.000175	0.00382	CcSEcCtD
Rosiglitazone—Dizziness—Diethylpropion—obesity	0.000173	0.00379	CcSEcCtD
Rosiglitazone—Diabetes mellitus—Topiramate—obesity	0.000173	0.00378	CcSEcCtD
Rosiglitazone—Sinusitis—Bupropion—obesity	0.00017	0.00373	CcSEcCtD
Rosiglitazone—PTGS1—cardiovascular system—obesity	0.00017	0.00973	CbGeAlD
Rosiglitazone—Diarrhoea—Cimetidine—obesity	0.00017	0.00373	CcSEcCtD
Rosiglitazone—Immune system disorder—Sibutramine—obesity	0.000169	0.0037	CcSEcCtD
Rosiglitazone—Malnutrition—Orlistat—obesity	0.000168	0.00369	CcSEcCtD
Rosiglitazone—Hepatic failure—Topiramate—obesity	0.000167	0.00366	CcSEcCtD
Rosiglitazone—CYP2C19—endocrine gland—obesity	0.000165	0.00943	CbGeAlD
Rosiglitazone—Rash—Diethylpropion—obesity	0.000165	0.00361	CcSEcCtD
Rosiglitazone—Dermatitis—Diethylpropion—obesity	0.000165	0.00361	CcSEcCtD
Rosiglitazone—Dizziness—Cimetidine—obesity	0.000164	0.0036	CcSEcCtD
Rosiglitazone—Headache—Diethylpropion—obesity	0.000164	0.00359	CcSEcCtD
Rosiglitazone—CYP1A2—digestive system—obesity	0.000163	0.00932	CbGeAlD
Rosiglitazone—Hepatitis—Bupropion—obesity	0.000163	0.00357	CcSEcCtD
Rosiglitazone—Malnutrition—Sibutramine—obesity	0.000163	0.00357	CcSEcCtD
Rosiglitazone—Back pain—Orlistat—obesity	0.000163	0.00357	CcSEcCtD
Rosiglitazone—Oedema peripheral—Bupropion—obesity	0.000161	0.00352	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Bupropion—obesity	0.00016	0.00351	CcSEcCtD
Rosiglitazone—Increased appetite—Topiramate—obesity	0.00016	0.0035	CcSEcCtD
Rosiglitazone—Back pain—Sibutramine—obesity	0.000157	0.00345	CcSEcCtD
Rosiglitazone—Rash—Cimetidine—obesity	0.000157	0.00344	CcSEcCtD
Rosiglitazone—Dermatitis—Cimetidine—obesity	0.000157	0.00343	CcSEcCtD
Rosiglitazone—Headache—Cimetidine—obesity	0.000156	0.00341	CcSEcCtD
Rosiglitazone—Nausea—Diethylpropion—obesity	0.000155	0.0034	CcSEcCtD
Rosiglitazone—CYP2C9—digestive system—obesity	0.000155	0.00885	CbGeAlD
Rosiglitazone—Erythema multiforme—Bupropion—obesity	0.000154	0.00338	CcSEcCtD
Rosiglitazone—Hypoglycaemia—Topiramate—obesity	0.000154	0.00337	CcSEcCtD
Rosiglitazone—Angioedema—Orlistat—obesity	0.000154	0.00337	CcSEcCtD
Rosiglitazone—Eye disorder—Bupropion—obesity	0.000152	0.00334	CcSEcCtD
Rosiglitazone—Cardiac disorder—Bupropion—obesity	0.000151	0.00332	CcSEcCtD
Rosiglitazone—PTGS1—pituitary gland—obesity	0.000151	0.00862	CbGeAlD
Rosiglitazone—Anaemia—Sibutramine—obesity	0.00015	0.0033	CcSEcCtD
Rosiglitazone—PTGS1—adipose tissue—obesity	0.00015	0.00858	CbGeAlD
Rosiglitazone—CYP2C19—liver—obesity	0.000149	0.0085	CbGeAlD
Rosiglitazone—Angioedema—Sibutramine—obesity	0.000149	0.00326	CcSEcCtD
Rosiglitazone—Nausea—Cimetidine—obesity	0.000148	0.00324	CcSEcCtD
Rosiglitazone—Immune system disorder—Bupropion—obesity	0.000147	0.00323	CcSEcCtD
Rosiglitazone—Leukopenia—Sibutramine—obesity	0.000146	0.00319	CcSEcCtD
Rosiglitazone—CYP2C8—endocrine gland—obesity	0.000144	0.00823	CbGeAlD
Rosiglitazone—Myalgia—Orlistat—obesity	0.000143	0.00314	CcSEcCtD
Rosiglitazone—Malnutrition—Bupropion—obesity	0.000142	0.00311	CcSEcCtD
Rosiglitazone—PTGS1—digestive system—obesity	0.000141	0.00808	CbGeAlD
Rosiglitazone—Hypertension—Sibutramine—obesity	0.000141	0.00308	CcSEcCtD
Rosiglitazone—Myalgia—Sibutramine—obesity	0.000139	0.00304	CcSEcCtD
Rosiglitazone—Arthralgia—Sibutramine—obesity	0.000139	0.00304	CcSEcCtD
Rosiglitazone—Oedema—Orlistat—obesity	0.000137	0.00301	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Orlistat—obesity	0.000137	0.00301	CcSEcCtD
Rosiglitazone—Back pain—Bupropion—obesity	0.000137	0.00301	CcSEcCtD
Rosiglitazone—Infection—Orlistat—obesity	0.000136	0.00299	CcSEcCtD
Rosiglitazone—CYP1A2—endocrine gland—obesity	0.000135	0.0077	CbGeAlD
Rosiglitazone—PTGS1—adrenal gland—obesity	0.000135	0.0077	CbGeAlD
Rosiglitazone—Nervous system disorder—Orlistat—obesity	0.000135	0.00295	CcSEcCtD
Rosiglitazone—Nasopharyngitis—Topiramate—obesity	0.000134	0.00294	CcSEcCtD
Rosiglitazone—Oedema—Sibutramine—obesity	0.000133	0.00291	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Sibutramine—obesity	0.000133	0.00291	CcSEcCtD
Rosiglitazone—Infection—Sibutramine—obesity	0.000132	0.00289	CcSEcCtD
Rosiglitazone—Anaemia—Bupropion—obesity	0.000131	0.00287	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Sibutramine—obesity	0.00013	0.00285	CcSEcCtD
Rosiglitazone—CYP2C8—liver—obesity	0.00013	0.00742	CbGeAlD
Rosiglitazone—Angioedema—Bupropion—obesity	0.00013	0.00284	CcSEcCtD
Rosiglitazone—CYP2C9—endocrine gland—obesity	0.000128	0.00731	CbGeAlD
Rosiglitazone—Leukopenia—Bupropion—obesity	0.000127	0.00278	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Orlistat—obesity	0.000125	0.00274	CcSEcCtD
Rosiglitazone—Hypertension—Bupropion—obesity	0.000123	0.00269	CcSEcCtD
Rosiglitazone—CYP1A2—liver—obesity	0.000122	0.00694	CbGeAlD
Rosiglitazone—Musculoskeletal discomfort—Sibutramine—obesity	0.000121	0.00265	CcSEcCtD
Rosiglitazone—Arthralgia—Bupropion—obesity	0.000121	0.00265	CcSEcCtD
Rosiglitazone—Myalgia—Bupropion—obesity	0.000121	0.00265	CcSEcCtD
Rosiglitazone—Upper respiratory tract infection—Topiramate—obesity	0.000121	0.00264	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Orlistat—obesity	0.000119	0.0026	CcSEcCtD
Rosiglitazone—Fatigue—Orlistat—obesity	0.000118	0.00259	CcSEcCtD
Rosiglitazone—Weight increased—Topiramate—obesity	0.000118	0.00259	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Topiramate—obesity	0.000117	0.00257	CcSEcCtD
Rosiglitazone—PTGS1—endocrine gland—obesity	0.000117	0.00667	CbGeAlD
Rosiglitazone—CYP2D6—digestive system—obesity	0.000116	0.00664	CbGeAlD
Rosiglitazone—Anaphylactic shock—Bupropion—obesity	0.000116	0.00254	CcSEcCtD
Rosiglitazone—Oedema—Bupropion—obesity	0.000116	0.00254	CcSEcCtD
Rosiglitazone—CYP2C9—liver—obesity	0.000115	0.00659	CbGeAlD
Rosiglitazone—Infection—Bupropion—obesity	0.000115	0.00252	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Topiramate—obesity	0.000115	0.00251	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Sibutramine—obesity	0.000115	0.00251	CcSEcCtD
Rosiglitazone—Constipation—Sibutramine—obesity	0.000114	0.00249	CcSEcCtD
Rosiglitazone—Nervous system disorder—Bupropion—obesity	0.000114	0.00249	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Bupropion—obesity	0.000113	0.00249	CcSEcCtD
Rosiglitazone—Urticaria—Orlistat—obesity	0.000109	0.00239	CcSEcCtD
Rosiglitazone—Sinusitis—Topiramate—obesity	0.000109	0.00238	CcSEcCtD
Rosiglitazone—Urticaria—Sibutramine—obesity	0.000106	0.00231	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Bupropion—obesity	0.000106	0.00231	CcSEcCtD
Rosiglitazone—Hepatitis—Topiramate—obesity	0.000104	0.00228	CcSEcCtD
Rosiglitazone—Oedema peripheral—Topiramate—obesity	0.000102	0.00224	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Topiramate—obesity	0.000102	0.00224	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Bupropion—obesity	0.0001	0.00219	CcSEcCtD
Rosiglitazone—Fatigue—Bupropion—obesity	9.98e-05	0.00219	CcSEcCtD
Rosiglitazone—Constipation—Bupropion—obesity	9.9e-05	0.00217	CcSEcCtD
Rosiglitazone—Asthenia—Orlistat—obesity	9.85e-05	0.00216	CcSEcCtD
Rosiglitazone—Erythema multiforme—Topiramate—obesity	9.82e-05	0.00215	CcSEcCtD
Rosiglitazone—Pruritus—Orlistat—obesity	9.71e-05	0.00213	CcSEcCtD
Rosiglitazone—Eye disorder—Topiramate—obesity	9.71e-05	0.00213	CcSEcCtD
Rosiglitazone—Cardiac disorder—Topiramate—obesity	9.64e-05	0.00211	CcSEcCtD
Rosiglitazone—CYP2D6—endocrine gland—obesity	9.6e-05	0.00549	CbGeAlD
Rosiglitazone—Asthenia—Sibutramine—obesity	9.53e-05	0.00209	CcSEcCtD
Rosiglitazone—Pruritus—Sibutramine—obesity	9.4e-05	0.00206	CcSEcCtD
Rosiglitazone—Diarrhoea—Orlistat—obesity	9.39e-05	0.00206	CcSEcCtD
Rosiglitazone—Immune system disorder—Topiramate—obesity	9.38e-05	0.00206	CcSEcCtD
Rosiglitazone—Urticaria—Bupropion—obesity	9.2e-05	0.00202	CcSEcCtD
Rosiglitazone—Diarrhoea—Sibutramine—obesity	9.09e-05	0.00199	CcSEcCtD
Rosiglitazone—Dizziness—Orlistat—obesity	9.08e-05	0.00199	CcSEcCtD
Rosiglitazone—Malnutrition—Topiramate—obesity	9.04e-05	0.00198	CcSEcCtD
Rosiglitazone—Dizziness—Sibutramine—obesity	8.78e-05	0.00193	CcSEcCtD
Rosiglitazone—Back pain—Topiramate—obesity	8.75e-05	0.00192	CcSEcCtD
Rosiglitazone—CYP2D6—liver—obesity	8.66e-05	0.00495	CbGeAlD
Rosiglitazone—Rash—Orlistat—obesity	8.66e-05	0.0019	CcSEcCtD
Rosiglitazone—Dermatitis—Orlistat—obesity	8.65e-05	0.0019	CcSEcCtD
Rosiglitazone—Headache—Orlistat—obesity	8.6e-05	0.00188	CcSEcCtD
Rosiglitazone—Rash—Sibutramine—obesity	8.38e-05	0.00184	CcSEcCtD
Rosiglitazone—Dermatitis—Sibutramine—obesity	8.37e-05	0.00183	CcSEcCtD
Rosiglitazone—Anaemia—Topiramate—obesity	8.36e-05	0.00183	CcSEcCtD
Rosiglitazone—Headache—Sibutramine—obesity	8.32e-05	0.00182	CcSEcCtD
Rosiglitazone—Asthenia—Bupropion—obesity	8.31e-05	0.00182	CcSEcCtD
Rosiglitazone—Pruritus—Bupropion—obesity	8.19e-05	0.0018	CcSEcCtD
Rosiglitazone—Nausea—Orlistat—obesity	8.15e-05	0.00179	CcSEcCtD
Rosiglitazone—Leukopenia—Topiramate—obesity	8.09e-05	0.00177	CcSEcCtD
Rosiglitazone—Diarrhoea—Bupropion—obesity	7.92e-05	0.00174	CcSEcCtD
Rosiglitazone—Nausea—Sibutramine—obesity	7.89e-05	0.00173	CcSEcCtD
Rosiglitazone—Hypertension—Topiramate—obesity	7.81e-05	0.00171	CcSEcCtD
Rosiglitazone—Myalgia—Topiramate—obesity	7.7e-05	0.00169	CcSEcCtD
Rosiglitazone—Arthralgia—Topiramate—obesity	7.7e-05	0.00169	CcSEcCtD
Rosiglitazone—Dizziness—Bupropion—obesity	7.66e-05	0.00168	CcSEcCtD
Rosiglitazone—Oedema—Topiramate—obesity	7.38e-05	0.00162	CcSEcCtD
Rosiglitazone—Infection—Topiramate—obesity	7.33e-05	0.00161	CcSEcCtD
Rosiglitazone—Rash—Bupropion—obesity	7.3e-05	0.0016	CcSEcCtD
Rosiglitazone—Dermatitis—Bupropion—obesity	7.3e-05	0.0016	CcSEcCtD
Rosiglitazone—Headache—Bupropion—obesity	7.26e-05	0.00159	CcSEcCtD
Rosiglitazone—Nervous system disorder—Topiramate—obesity	7.24e-05	0.00159	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Topiramate—obesity	7.22e-05	0.00158	CcSEcCtD
Rosiglitazone—Nausea—Bupropion—obesity	6.88e-05	0.00151	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Topiramate—obesity	6.72e-05	0.00147	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Topiramate—obesity	6.37e-05	0.0014	CcSEcCtD
Rosiglitazone—Fatigue—Topiramate—obesity	6.36e-05	0.00139	CcSEcCtD
Rosiglitazone—Constipation—Topiramate—obesity	6.31e-05	0.00138	CcSEcCtD
Rosiglitazone—Urticaria—Topiramate—obesity	5.86e-05	0.00128	CcSEcCtD
Rosiglitazone—Asthenia—Topiramate—obesity	5.29e-05	0.00116	CcSEcCtD
Rosiglitazone—Pruritus—Topiramate—obesity	5.22e-05	0.00114	CcSEcCtD
Rosiglitazone—Diarrhoea—Topiramate—obesity	5.05e-05	0.00111	CcSEcCtD
Rosiglitazone—Dizziness—Topiramate—obesity	4.88e-05	0.00107	CcSEcCtD
Rosiglitazone—Rash—Topiramate—obesity	4.65e-05	0.00102	CcSEcCtD
Rosiglitazone—Dermatitis—Topiramate—obesity	4.65e-05	0.00102	CcSEcCtD
Rosiglitazone—Headache—Topiramate—obesity	4.62e-05	0.00101	CcSEcCtD
Rosiglitazone—Nausea—Topiramate—obesity	4.38e-05	0.000961	CcSEcCtD
Rosiglitazone—PTGS1—Metabolism—POMC—obesity	1.41e-06	2.09e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—COMT—obesity	1.4e-06	2.09e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—INS—obesity	1.4e-06	2.08e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—COMT—obesity	1.4e-06	2.08e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PIK3CG—obesity	1.4e-06	2.08e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CYP2E1—obesity	1.39e-06	2.07e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GOT1—obesity	1.39e-06	2.07e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GGT1—obesity	1.39e-06	2.07e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CETP—obesity	1.39e-06	2.07e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GNB3—obesity	1.38e-06	2.06e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PPARGC1A—obesity	1.38e-06	2.06e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CYP2E1—obesity	1.38e-06	2.06e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—HMOX1—obesity	1.38e-06	2.05e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—NOS3—obesity	1.38e-06	2.05e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PIK3R1—obesity	1.38e-06	2.05e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GNB3—obesity	1.38e-06	2.05e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PPARGC1A—obesity	1.38e-06	2.05e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—NQO1—obesity	1.38e-06	2.05e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—SDC1—obesity	1.37e-06	2.04e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—HMOX1—obesity	1.37e-06	2.04e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—NCOA1—obesity	1.37e-06	2.04e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—NQO1—obesity	1.36e-06	2.03e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—AKR1C3—obesity	1.35e-06	2.01e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—STK11—obesity	1.35e-06	2.01e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CYP19A1—obesity	1.35e-06	2.01e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GNAS—obesity	1.35e-06	2.01e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PPARG—obesity	1.35e-06	2.01e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GNAS—obesity	1.34e-06	2e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—obesity	1.34e-06	1.99e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—POMC—obesity	1.33e-06	1.98e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—SCARB1—obesity	1.33e-06	1.98e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—obesity	1.32e-06	1.97e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—INS—obesity	1.32e-06	1.97e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—APOB—obesity	1.32e-06	1.97e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GCG—obesity	1.32e-06	1.97e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—SLC2A4—obesity	1.32e-06	1.97e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—APOB—obesity	1.31e-06	1.96e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—obesity	1.31e-06	1.95e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GCG—obesity	1.31e-06	1.95e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—SLC2A4—obesity	1.31e-06	1.95e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CYCS—obesity	1.3e-06	1.94e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PIK3CD—obesity	1.3e-06	1.93e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—obesity	1.29e-06	1.93e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CYCS—obesity	1.29e-06	1.92e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—SREBF1—obesity	1.29e-06	1.92e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—TGFB1—obesity	1.28e-06	1.91e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—ALB—obesity	1.28e-06	1.91e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GOT1—obesity	1.28e-06	1.9e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GGT1—obesity	1.28e-06	1.9e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PIK3CB—obesity	1.27e-06	1.89e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GGT1—obesity	1.27e-06	1.89e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GOT1—obesity	1.27e-06	1.89e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—LPL—obesity	1.26e-06	1.88e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PTGS2—obesity	1.26e-06	1.88e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—NCOA1—obesity	1.26e-06	1.87e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GOT2—obesity	1.25e-06	1.87e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—LPL—obesity	1.25e-06	1.87e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—COMT—obesity	1.25e-06	1.87e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—NCOA1—obesity	1.25e-06	1.86e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—STK11—obesity	1.24e-06	1.85e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CYP19A1—obesity	1.24e-06	1.85e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—obesity	1.24e-06	1.84e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PPARGC1A—obesity	1.24e-06	1.84e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GNB3—obesity	1.24e-06	1.84e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—HMOX1—obesity	1.23e-06	1.83e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GPX1—obesity	1.23e-06	1.83e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CYP19A1—obesity	1.23e-06	1.83e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—STK11—obesity	1.23e-06	1.83e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PIK3CD—obesity	1.23e-06	1.83e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—FASN—obesity	1.23e-06	1.83e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PIK3R1—obesity	1.23e-06	1.83e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—NOS3—obesity	1.23e-06	1.83e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GPX1—obesity	1.22e-06	1.82e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—BCHE—obesity	1.22e-06	1.82e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—ALB—obesity	1.21e-06	1.81e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GNAS—obesity	1.2e-06	1.79e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CD36—obesity	1.2e-06	1.78e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CD36—obesity	1.19e-06	1.77e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CYP2E1—obesity	1.18e-06	1.76e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—APOB—obesity	1.18e-06	1.76e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—NQO1—obesity	1.17e-06	1.74e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PIK3R1—obesity	1.16e-06	1.73e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—NOS3—obesity	1.16e-06	1.73e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—COMT—obesity	1.15e-06	1.72e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—COMT—obesity	1.14e-06	1.7e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—obesity	1.14e-06	1.7e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GNB3—obesity	1.14e-06	1.69e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PPARGC1A—obesity	1.14e-06	1.69e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—MTHFR—obesity	1.14e-06	1.69e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—HMOX1—obesity	1.13e-06	1.69e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PIK3CB—obesity	1.13e-06	1.69e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—obesity	1.13e-06	1.68e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—MTHFR—obesity	1.13e-06	1.68e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PPARGC1A—obesity	1.13e-06	1.68e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GNB3—obesity	1.13e-06	1.68e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—LPL—obesity	1.13e-06	1.68e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—HMOX1—obesity	1.12e-06	1.67e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PTGS2—obesity	1.12e-06	1.67e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GCG—obesity	1.12e-06	1.66e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—SLC2A4—obesity	1.12e-06	1.66e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PPARA—obesity	1.11e-06	1.66e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PPARA—obesity	1.11e-06	1.65e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GNAS—obesity	1.11e-06	1.65e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CYCS—obesity	1.1e-06	1.64e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GPX1—obesity	1.1e-06	1.64e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GNAS—obesity	1.1e-06	1.63e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—PIK3CA—obesity	1.09e-06	1.63e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—APOB—obesity	1.08e-06	1.61e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GGT1—obesity	1.08e-06	1.61e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GOT1—obesity	1.08e-06	1.61e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—AGT—obesity	1.08e-06	1.61e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—APOB—obesity	1.07e-06	1.6e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—AGT—obesity	1.07e-06	1.6e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PIK3CB—obesity	1.07e-06	1.59e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CD36—obesity	1.07e-06	1.59e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—NCOA1—obesity	1.07e-06	1.59e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PTGS2—obesity	1.06e-06	1.58e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—APOE—obesity	1.06e-06	1.57e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—APOE—obesity	1.05e-06	1.57e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—STK11—obesity	1.05e-06	1.57e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CYP19A1—obesity	1.05e-06	1.57e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CAV1—obesity	1.05e-06	1.56e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—APOA1—obesity	1.04e-06	1.56e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CAV1—obesity	1.04e-06	1.55e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—APOA1—obesity	1.04e-06	1.55e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—LPL—obesity	1.03e-06	1.54e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—AKT1—obesity	1.03e-06	1.54e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—LPL—obesity	1.03e-06	1.53e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—MTHFR—obesity	1.01e-06	1.51e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GPX1—obesity	1.01e-06	1.5e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GPX1—obesity	1e-06	1.49e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1e-06	1.49e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—obesity	9.95e-07	1.48e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PPARA—obesity	9.94e-07	1.48e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PIK3CA—obesity	9.84e-07	1.47e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CD36—obesity	9.83e-07	1.47e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—COMT—obesity	9.77e-07	1.46e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CD36—obesity	9.75e-07	1.45e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GNB3—obesity	9.63e-07	1.43e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PPARGC1A—obesity	9.63e-07	1.43e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—AGT—obesity	9.63e-07	1.43e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—HMOX1—obesity	9.59e-07	1.43e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PIK3CG—obesity	9.54e-07	1.42e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PIK3CG—obesity	9.48e-07	1.41e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—APOE—obesity	9.43e-07	1.41e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GNAS—obesity	9.38e-07	1.4e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CAV1—obesity	9.34e-07	1.39e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—APOA1—obesity	9.32e-07	1.39e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—MTHFR—obesity	9.32e-07	1.39e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—MTHFR—obesity	9.24e-07	1.38e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PPARG—obesity	9.2e-07	1.37e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—APOB—obesity	9.18e-07	1.37e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PPARG—obesity	9.15e-07	1.36e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PPARA—obesity	9.14e-07	1.36e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—POMC—obesity	9.08e-07	1.35e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PPARA—obesity	9.06e-07	1.35e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—INS—obesity	9.03e-07	1.35e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—POMC—obesity	9.03e-07	1.34e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—INS—obesity	8.98e-07	1.34e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—obesity	8.93e-07	1.33e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—AKT1—obesity	8.92e-07	1.33e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—AGT—obesity	8.85e-07	1.32e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—AGT—obesity	8.78e-07	1.31e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—LPL—obesity	8.77e-07	1.31e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—APOE—obesity	8.67e-07	1.29e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—APOE—obesity	8.6e-07	1.28e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CAV1—obesity	8.59e-07	1.28e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—APOA1—obesity	8.58e-07	1.28e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GPX1—obesity	8.55e-07	1.27e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CAV1—obesity	8.52e-07	1.27e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PIK3CG—obesity	8.51e-07	1.27e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—APOA1—obesity	8.5e-07	1.27e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PIK3CD—obesity	8.38e-07	1.25e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PIK3CD—obesity	8.34e-07	1.24e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CD36—obesity	8.33e-07	1.24e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ALB—obesity	8.28e-07	1.23e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PPARG—obesity	8.22e-07	1.22e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—obesity	8.14e-07	1.21e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—POMC—obesity	8.1e-07	1.21e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—INS—obesity	8.06e-07	1.2e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—AKT1—obesity	8.04e-07	1.2e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PIK3R1—obesity	7.92e-07	1.18e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—NOS3—obesity	7.92e-07	1.18e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—MTHFR—obesity	7.89e-07	1.18e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PIK3R1—obesity	7.87e-07	1.17e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—NOS3—obesity	7.87e-07	1.17e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PIK3CG—obesity	7.83e-07	1.17e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PIK3CG—obesity	7.76e-07	1.16e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PIK3CA—obesity	7.75e-07	1.16e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PPARA—obesity	7.74e-07	1.15e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PPARG—obesity	7.56e-07	1.13e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—AGT—obesity	7.5e-07	1.12e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PPARG—obesity	7.49e-07	1.12e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PIK3CD—obesity	7.48e-07	1.11e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—POMC—obesity	7.45e-07	1.11e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—INS—obesity	7.41e-07	1.1e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—POMC—obesity	7.39e-07	1.1e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ALB—obesity	7.39e-07	1.1e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—APOE—obesity	7.35e-07	1.1e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—INS—obesity	7.35e-07	1.09e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PIK3CB—obesity	7.31e-07	1.09e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CAV1—obesity	7.28e-07	1.08e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PIK3CB—obesity	7.27e-07	1.08e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—APOA1—obesity	7.26e-07	1.08e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PTGS2—obesity	7.24e-07	1.08e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PTGS2—obesity	7.2e-07	1.07e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PIK3R1—obesity	7.07e-07	1.05e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—NOS3—obesity	7.07e-07	1.05e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	6.96e-07	1.04e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PIK3CA—obesity	6.9e-07	1.03e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PIK3CD—obesity	6.88e-07	1.03e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PIK3CD—obesity	6.82e-07	1.02e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ALB—obesity	6.79e-07	1.01e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ALB—obesity	6.74e-07	1e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PIK3CG—obesity	6.63e-07	9.88e-06	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PIK3CB—obesity	6.52e-07	9.72e-06	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PIK3CA—obesity	6.52e-07	9.72e-06	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PIK3R1—obesity	6.5e-07	9.68e-06	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—NOS3—obesity	6.5e-07	9.68e-06	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PTGS2—obesity	6.46e-07	9.63e-06	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—NOS3—obesity	6.44e-07	9.6e-06	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PIK3R1—obesity	6.44e-07	9.6e-06	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PPARG—obesity	6.4e-07	9.54e-06	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—AKT1—obesity	6.33e-07	9.44e-06	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—POMC—obesity	6.31e-07	9.41e-06	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—INS—obesity	6.28e-07	9.35e-06	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PIK3CB—obesity	6e-07	8.94e-06	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PIK3CB—obesity	5.95e-07	8.86e-06	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PTGS2—obesity	5.94e-07	8.86e-06	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PTGS2—obesity	5.89e-07	8.78e-06	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PIK3CD—obesity	5.83e-07	8.69e-06	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ALB—obesity	5.76e-07	8.58e-06	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—AKT1—obesity	5.63e-07	8.39e-06	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—NOS3—obesity	5.51e-07	8.2e-06	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PIK3R1—obesity	5.51e-07	8.2e-06	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—AKT1—obesity	5.33e-07	7.94e-06	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PIK3CB—obesity	5.08e-07	7.57e-06	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PTGS2—obesity	5.04e-07	7.5e-06	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PIK3CA—obesity	4.45e-07	6.64e-06	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PIK3CA—obesity	4.43e-07	6.6e-06	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PIK3CA—obesity	3.98e-07	5.92e-06	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PIK3CA—obesity	3.66e-07	5.45e-06	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—AKT1—obesity	3.64e-07	5.42e-06	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PIK3CA—obesity	3.63e-07	5.4e-06	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—AKT1—obesity	3.62e-07	5.39e-06	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—AKT1—obesity	3.25e-07	4.84e-06	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PIK3CA—obesity	3.1e-07	4.62e-06	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—AKT1—obesity	2.99e-07	4.45e-06	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—AKT1—obesity	2.96e-07	4.41e-06	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—AKT1—obesity	2.53e-07	3.77e-06	CbGpPWpGaD
